FI65996C - Foerfarande foer framstaellning av terapeutiskt anvaendbara n-2-furylmetyl)-5-sulfamoyl-ortanilsyror och deras salter - Google Patents

Foerfarande foer framstaellning av terapeutiskt anvaendbara n-2-furylmetyl)-5-sulfamoyl-ortanilsyror och deras salter Download PDF

Info

Publication number
FI65996C
FI65996C FI781305A FI781305A FI65996C FI 65996 C FI65996 C FI 65996C FI 781305 A FI781305 A FI 781305A FI 781305 A FI781305 A FI 781305A FI 65996 C FI65996 C FI 65996C
Authority
FI
Finland
Prior art keywords
formula
acid
sulfamoyl
group
furylmethyl
Prior art date
Application number
FI781305A
Other languages
English (en)
Finnish (fi)
Other versions
FI65996B (fi
FI781305A (fi
Inventor
Karl Sturm
Roman Muschaweck
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of FI781305A publication Critical patent/FI781305A/fi
Publication of FI65996B publication Critical patent/FI65996B/fi
Application granted granted Critical
Publication of FI65996C publication Critical patent/FI65996C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
FI781305A 1977-04-28 1978-04-26 Foerfarande foer framstaellning av terapeutiskt anvaendbara n-2-furylmetyl)-5-sulfamoyl-ortanilsyror och deras salter FI65996C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2718871A DE2718871C3 (de) 1977-04-28 1977-04-28 N-(2-Furylmethyl)-5-sulfamoylorthanilsäuren und deren physiologisch verträgliche Salze und Verfahren zu ihrer Herstellung und ihre Verwendung bei der Bekämpfung von Oedemkrankheiten und Bluthochdruck
DE2718871 1977-04-28

Publications (3)

Publication Number Publication Date
FI781305A FI781305A (fi) 1978-10-29
FI65996B FI65996B (fi) 1984-04-30
FI65996C true FI65996C (fi) 1984-08-10

Family

ID=6007484

Family Applications (1)

Application Number Title Priority Date Filing Date
FI781305A FI65996C (fi) 1977-04-28 1978-04-26 Foerfarande foer framstaellning av terapeutiskt anvaendbara n-2-furylmetyl)-5-sulfamoyl-ortanilsyror och deras salter

Country Status (18)

Country Link
US (1) US4161533A (sv)
JP (1) JPS53135966A (sv)
AT (1) AT363463B (sv)
BE (1) BE866565A (sv)
CA (1) CA1109477A (sv)
CH (1) CH638798A5 (sv)
DE (1) DE2718871C3 (sv)
DK (1) DK183678A (sv)
ES (1) ES469058A1 (sv)
FI (1) FI65996C (sv)
FR (1) FR2388809A1 (sv)
GB (1) GB1587105A (sv)
HU (1) HU177454B (sv)
IL (1) IL54585A (sv)
IT (1) IT1094565B (sv)
NL (1) NL7804558A (sv)
SE (1) SE439012B (sv)
ZA (1) ZA782421B (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3009229A1 (de) * 1980-03-11 1981-10-15 Hoechst Ag, 6000 Frankfurt 2,4-diamino-5-sulfamoylbenzolsulfosaeuren und verfahen zu ihrer herstellung
DE3034880A1 (de) * 1980-09-16 1982-04-29 Hoechst Ag, 6000 Frankfurt Verfahren zur herstellung von 5- sulfamoyl-orthanilsaeuren
FR2614619B1 (fr) * 1987-04-29 1989-09-15 Sanofi Sa Procede de preparation de n-((chloro-2)-benzyl) (thienyl-2)-2 ethylamine
WO2005082350A1 (en) * 2004-02-20 2005-09-09 Aventis Pharmaceuticals Inc. Furosemide derivatives as modulators of hm74 and their use for the treatment of inflammation

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1802208U (de) 1959-10-01 1959-12-17 Hugo Guddar Verschluss fuer pelze aller art.
DE1122541B (de) 1959-12-28 1962-01-25 Hoechst Ag Verfahren zur Herstellung von Sulfamyl-anthranilsaeuren
CH383403A (de) 1960-12-23 1964-10-31 Sandoz Ag Verfahren zur Herstellung von neuen Sulfonamiden
DE1278443C2 (de) * 1963-11-30 1975-07-24 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von 2,4-disulfonamid-1-chlorbenzolen
DE1543602C3 (de) 1966-06-16 1974-09-26 Bayer Ag, 5090 Leverkusen Substituierte Disulfonamide sowie deren Salze mit nichttoxischen Basen und Verfahren zu ihrer Herstellung
US3454562A (en) * 1966-10-07 1969-07-08 Smithkline Corp 5 - carbamoylsulfamoyl - n - substitutedanthranilic acids and esters thereof
DE1802208A1 (de) * 1968-10-10 1970-05-14 Hoechst Ag Verfahren zur Herstellung salidiuretisch wirksamer Sulfamylanthranilsaeuren
US3875150A (en) 1969-04-29 1975-04-01 Leo Pharm Prod Ltd New sulfamyl-anthranilic acids
DE2247828A1 (de) 1972-09-29 1974-04-04 Hoechst Ag Sulfamoyl-anthranilsaeuren und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
FI65996B (fi) 1984-04-30
AT363463B (de) 1981-08-10
GB1587105A (en) 1981-04-01
DE2718871A1 (de) 1978-11-09
IT7822729A0 (it) 1978-04-26
SE7804956L (sv) 1978-10-29
FI781305A (fi) 1978-10-29
IL54585A (en) 1982-05-31
SE439012B (sv) 1985-05-28
DK183678A (da) 1978-10-29
US4161533A (en) 1979-07-17
ZA782421B (en) 1979-04-25
JPS53135966A (en) 1978-11-28
CA1109477A (en) 1981-09-22
HU177454B (en) 1981-10-28
FR2388809A1 (fr) 1978-11-24
FR2388809B1 (sv) 1980-10-31
NL7804558A (nl) 1978-10-31
ATA305278A (de) 1981-01-15
DE2718871B2 (de) 1979-10-31
IL54585A0 (en) 1978-07-31
AU3548678A (en) 1979-11-01
IT1094565B (it) 1985-08-02
ES469058A1 (es) 1978-11-16
CH638798A5 (de) 1983-10-14
DE2718871C3 (de) 1980-07-17
BE866565A (fr) 1978-10-30

Similar Documents

Publication Publication Date Title
Cain et al. Potential antitumor agents. 16. 4'-(Acridin-9-ylamino) methanesulfonanilides
PT95655B (pt) Processo para a preparacao de derivados de benzimidazol
JPH03169863A (ja) 窒素化合物
JP6374436B2 (ja) 純粋なエルロチニブ
HU183087B (en) Process for producing substituted pyrano- and thiopyrano-quinolines
DE3419009A1 (de) Neue substituierte bis(4-aminophenyl)sulfone, ihre herstellung und ihre verwendung als arzneimittel
FI65996C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara n-2-furylmetyl)-5-sulfamoyl-ortanilsyror och deras salter
Cain et al. Potential antitumor agents. 19. Multiply substituted 4'-(9-acridinylamino) methanesulfonanilides
FI57104C (fi) Foerfarande foer framstaellning av befruktningshindrande nya s-triatsolo(5,1-a)isokinolinderivat
JPS6254786B2 (sv)
KR940003759B1 (ko) 4-oh 퀴놀린 카르복실산 유도체의 제조방법
US3740413A (en) 2-benzimidazolecarboxamides
JPS58170747A (ja) 2−アミノメチル−6−スルフアモイルフエノ−ル誘導体
KR950011412B1 (ko) 신규한 이소퀴놀린 화합물(들)과 이들을 함유하는 약제학적 조성물 및 그들의 제조방법
SU858566A3 (ru) Способ получени четвертичных производных ксантинилалкилнортропина
EP0093515B1 (en) Tricyclic triazino compounds, their use and formulation as pharmaceuticals and processes for their production
KR800001218B1 (ko) 티아졸리닐 케로벤즈아미다졸 및 이의 유도체의 제조방법
FI58921C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 2-substituerade-oxazolo-(5,4-b)-pyridiner
Morley et al. 410. Some Bz-substituted-3-nitroquinolines
KR790001739B1 (ko) 벤즈아미드 유도체의 제조법
KR800001138B1 (ko) 카보닐-치환-1-설포닐 벤즈이미다졸류의 제조방법
KR810001896B1 (ko) 1-설포닐-5(6)-치환된 벤즈이미다졸의 제조 방법
KR820000099B1 (ko) 피리도[2, 1-b] 퀴나졸린 유도체의 제조방법
Kaslow et al. Diquinolylmethanes
KR790001432B1 (ko) 티아졸리닐 또는 티아지닐 벤즈이미다졸 에스테르의 제조방법

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: HOECHST AKTIENGESELLSCHAFT